Last updated: January 24, 2024
Sponsor: Ankara City Hospital Bilkent
Overall Status: Completed
Phase
N/A
Condition
Peripheral Neuropathy
Neuropathy
Chronic Pain
Treatment
Radiofrequency ablation
Clinical Study ID
NCT06240000
ankarasehir.kam@saglik.gov.tr
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Suffering from chronic low back pain more than 3 months
- Age ≥ 18
- VAS score ≥ 3/10
- According to the blood samples, there should not be any detected bleeding diathesis (INR ≤1.2)
- Patients detected positive 'iliac crest sign' included in the study
Exclusion
Exclusion Criteria:
- Patients have pain score <3 according to the Visual Analog Scale (VAS)
- INR >1.2 in blood samples
- Radicular pain accompanying progressive neurological deficit
- Sphincter disorder due to neurologic conditions
- Local infections
- Sepsis
- Malignancy
- Uncontrolled diabetes or other comorbidities leading general condition disorders
- Allergic history related to used materials
- Pregnancy
- Mental disorders worsen cooperation were excluded from the study.
Study Design
Total Participants: 25
Treatment Group(s): 1
Primary Treatment: Radiofrequency ablation
Phase:
Study Start date:
April 01, 2023
Estimated Completion Date:
January 01, 2024
Connect with a study center
Ankara Bilkent City Hospital
Ankara, 00680
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.